LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2018

Apr 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2018-04-27

Reporting Person: Palantoni Frank (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-27	Common Stock	A	2564	—	Acquired	12902	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-27	Stock Option (Right to Buy)	$7.80	A	2857	Acquired	2028-04-27	Common Stock (2857)	Direct

Footnotes

F1: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant.